127 related articles for article (PubMed ID: 11780328)
21. Evaluation of an adenoviral vector encoding full-length human factor VIII in hemophiliac mice.
Connelly S; Andrews JL; Gallo-Penn AM; Tagliavacca L; Kaufman RJ; Kaleko M
Thromb Haemost; 1999 Feb; 81(2):234-9. PubMed ID: 10063998
[TBL] [Abstract][Full Text] [Related]
22. Sustained expansion and transgene expression of coagulation factor VIII-transduced cord blood-derived endothelial progenitor cells.
Herder C; Tonn T; Oostendorp R; Becker S; Keller U; Peschel C; Grez M; Seifried E
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2266-72. PubMed ID: 14551158
[TBL] [Abstract][Full Text] [Related]
23. Construction and high expression of retroviral vector with human clotting factor IX cDNA in vitro.
Lu D; Qiu X; Zheng B; Qiu X; Xue J
Sci China B; 1995 Jun; 38(6):705-12. PubMed ID: 7626200
[TBL] [Abstract][Full Text] [Related]
24. Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A.
Zhang WW; Josephs SF; Zhou J; Fang X; Alemany R; Balagué C; Dai Y; Ayares D; Prokopenko E; Lou YC; Sethi E; Hubert-Leslie D; Kennedy M; Ruiz L; Rockow-Magnone S
Thromb Haemost; 1999 Aug; 82(2):562-71. PubMed ID: 10605752
[TBL] [Abstract][Full Text] [Related]
25. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
Van Damme A; Chuah MK; Collen D; VandenDriessche T
Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
[TBL] [Abstract][Full Text] [Related]
26. Sustained expression of Epstein-Barr virus episomal vector mediated factor VIII in vivo following muscle electroporation.
Mei WH; Qian GX; Zhang XQ; Zhang P; Lu J
Haemophilia; 2006 May; 12(3):271-9. PubMed ID: 16643213
[TBL] [Abstract][Full Text] [Related]
27. Sustaining expression of B domain-deleted human factor VIII mediated by using lentiviral vectors in NOD/SCID mouse.
Li YJ; Chen C; Zeng LY; Cao J; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):658-63. PubMed ID: 22739177
[TBL] [Abstract][Full Text] [Related]
28. Analysis of factor VIII mediated suppression of lentiviral vector titres.
Radcliffe PA; Sion CJ; Wilkes FJ; Custard EJ; Beard GL; Kingsman SM; Mitrophanous KA
Gene Ther; 2008 Feb; 15(4):289-97. PubMed ID: 18046428
[TBL] [Abstract][Full Text] [Related]
29. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice.
Chuah MK; Van Damme A; Zwinnen H; Goovaerts I; Vanslembrouck V; Collen D; VandenDriessche T
Hum Gene Ther; 2000 Mar; 11(5):729-38. PubMed ID: 10757352
[TBL] [Abstract][Full Text] [Related]
30. Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.
Hong Y; Yu SS; Kim JM; Lee K; Na YS; Whitley CB; Sugimoto Y; Kim S
J Gene Med; 2003 Jan; 5(1):18-29. PubMed ID: 12516048
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional activation of the factor VIII gene in liver cell lines by interleukin-6.
Stirling D; Hannant WA; Ludlam CA
Thromb Haemost; 1998 Jan; 79(1):74-8. PubMed ID: 9459327
[TBL] [Abstract][Full Text] [Related]
32. [In vitro expression of human factor VIII gene induced by sodium butyrate].
Yin J; Wang H; Wang X; Chu H; Li D; Chen H; Fu Q; Duan B; Kang W; Ding Q; Qi Z; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):463-5. PubMed ID: 12482356
[TBL] [Abstract][Full Text] [Related]
33. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.
Gharagozlou S; Ghods R; Bahrami ZS; Roohi A; Jeddi-Tehrani M; Conti-Fine BM; Sharifian RA; Rabbani H; Shokri F
Hum Antibodies; 2003; 12(3):67-76. PubMed ID: 14646035
[TBL] [Abstract][Full Text] [Related]
34. [Enhancing effect of porcine coagulation factor VIII A1 and A3 domains on secretion of post-translationally spliced human/porcine hybrid coagulation factor VIII].
Zhu FX; Liu ZL; Qu HG; Chi XY
Sheng Li Xue Bao; 2010 Aug; 62(4):373-81. PubMed ID: 20717639
[TBL] [Abstract][Full Text] [Related]
35. [Construction and identification of recombinant retroviral vector containing human interleukin 1 receptor antagonist and its expression in osteoarthritic human articular chondrocytes].
Rui Y; Wang Y; Zhang X; Sun H; Qu Z; Dai K
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 May; 22(5):533-8. PubMed ID: 18630429
[TBL] [Abstract][Full Text] [Related]
36. [Non-viral vector mediating human coagulation factor VIII gene expression in mouse 32D cell line].
Yin J; Wang HL; Wang XF; Qu B; Wu WM; Ding QL; Fu QH; Qi ZW; Wang ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):721-5. PubMed ID: 15631647
[TBL] [Abstract][Full Text] [Related]
37. [Expression of B domain-deleted human coagulant factor VIII gene in 293T cells mediated by lentiviral vector in vitro].
Cheng H; Xu KL; Sun HY; DU B; Zeng LY; Lu QX; He XP; Pan XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1074-8. PubMed ID: 17956694
[TBL] [Abstract][Full Text] [Related]
38. Identification of a novel immunodominant cytotoxic T lymphocyte epitope derived from human factor VIII in a murine model of hemophilia A.
Wang W; Merchlinsky M; Inman J; Golding B
Thromb Res; 2005; 116(4):335-44. PubMed ID: 16038719
[TBL] [Abstract][Full Text] [Related]
39. [Leucine zippers improves protein splicing-mediated coagulation factor VIII gene delivery by dual-vector system].
Zhu FX; Yang SD; Liu ZL; Miao J; Qu HG; Chi XY
Yao Xue Xue Bao; 2012 Jan; 47(1):39-44. PubMed ID: 22493803
[TBL] [Abstract][Full Text] [Related]
40. [Construction and application of retroviral vector system useful for high-efficiency transfection into human T cells].
Zhang RP; Yun L; Peng L; Lu B; Zhou Q; Wang H; Guo YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):420-2, 426. PubMed ID: 16805997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
